Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and biphosphonate treatment
- 1 April 1986
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (4) , 493-500
- https://doi.org/10.1016/0277-5379(86)90117-3
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- LOCATION OF METASTATIC BREAST CARCINOMA BY A MONOCLONAL ANTIBODY CHELATE LABELLED WITH INDIUM-111The Lancet, 1983
- Bone scanning in patients with early breast carcinoma: Should it be a routine staging procedure?Cancer, 1981
- The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sectionsBritish Journal of Cancer, 1980
- Prognostic value of pretreatment bone scans in breast carcinomaAmerican Journal of Roentgenology, 1979
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Efficacy of Preoperative and Postoperative Bone Scanning in the Management of Breast CarcinomaNew England Journal of Medicine, 1977
- Evaluation of routine pre-operative bone scintigraphy in patients with breast cancerPublished by Elsevier ,1977
- Clinical Problems: Hypercalcaemia in Patients with Advanced Mammary CancerBMJ, 1971
- Metastases in carcinoma.Analysis of 1000 autopsied casesCancer, 1950
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889